Table 1:

Intra-arterial chemotherapy for retinoblastoma in infants weighing ≤10 kg (74 treated eyes with 222 IAC sessions)—patient demographics

VariableWeight ≤ 10 kg (n = 74 Eyes; 35.7% of 69 Patients)Weight >10 kg (n = 133 Eyes; 64.2% of 127 Patients)P ValueTotal (n = 207) Eyes (%) of 196 Patients
Age at presentation (months) (n = 196), mean (median, range)10 (9, 1–33)32 (23, 4–387).0124 (15, 1–387)
Age at time of first IAC (months) (n = 196), mean (median, range)11 (10, 3–30)35 (25, 4–387).0124 (15, 1–387)
Weight at first IAC (kg) (n = 196), mean (median, range)8.4 (8.9, 3.1–10.4)16.4 (13.3, 10.3–209).0113.5 (11.5, 3.1–209)
Sex (n = 196)
 Male36 (52.2)68 (53.5).85104 (53.1)
 Female33 (47.8)59 (46.5)92 (47.8)
Race (n = 196)
 White37 (53.6)59 (46.5).3196 (49.0)
 Asian12 (17.4)26 (20.5)38 (19.4)
 African American11 (16.0)21 (16.5)32 (16.3)
 Hispanic9 (13.0)12 (9.4)21 (10.7)
 Other09 (7.1)9 (4.6)
Family history (n = 196)4 (5.8)8 (6.2).8812 (6.1)
Genetics (n = 196)
 Somatic31 (44.9)51 (40.2).2982 (41.8)
 Germline20 (28.9)38 (29.9)58 (29.6)
 13q deletion syndrome2 (2.9)0 (0.0)2 (1.0)
 Unavailable16 (23.2)38 (29.9)54 (27.6)
Laterality of disease (n = 196)
 Unilateral55 (79.7)91 (71.7).21146 (74.5)
 Bilateral14 (20.3)36 (28.3)50 (25.5)
Involved eye (n = 196)
 Right eye31 (41.9)66 (49.6).1997 (49.5)
 Left eye43 (58.1)67 (50.4)110 (56.1)